New test gauges danger of rejection when children need organ transplants
from Managed Care Magazine
By measuring the inflammatory marker CD154, Pleximmune promises to predict the risk of organ rejection in liver and small-bowel transplant procedures.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063